Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Ampicillin | Research article

Common uropathogens and their antibiotic susceptibility pattern among diabetic patients

Authors: Hiwot Ketema Woldemariam, Dereje Assefa Geleta, Kassu Desta Tulu, Negga Asamene Aber, Melese Hailu Legese, Genet Molla Fenta, Ibrahim Ali

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Urinary tract infection (UTIs) is a significant health problem in diabetic patients because of the multiple effects of this disease on the urinary tract and host immune system. Complicated UTIs occur most commonly in patients with abnormal genitourinary tract. Proper investigation and prompt treatment are needed to prevent morbidity and serious life threatening condition associated with UTI and diabetes co-morbidities.

Objective

To determine common uropathogens and antibiotic susceptibility patterns with associated risk factors among adult diabetic patients attending at St. Paul Specialized Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Methods

A hospital based, cross-sectional study was conducted from April–July 2015. A total of 248 diabetic patients with asymptomatic and symptomatic UTI were investigated for common uropathogens. Clean catch mid-stream urine specimens were collected from each study subjects. Uropathogens were isolated and identified by using conventional standard techniques. Samples were cultured on Blood agar, MacConkey agar and Sabouraud Dextrose Agar. Antibiotic Susceptibility pattern was determined on Mueller-Hinton using Kirby –Bauer disc diffusion method. The collected data and the result of the laboratory were analyzed using SPSS version 20.

Results

The overall prevalence of uropathogens among diabetic patients was 56/248(22.6%) of which 21/177(11.9%) and 35/71(49.3%) had asymptomatic and symptomatic UTI respectively. E. coli 13/56(23.2%), Coagulase negative Staphylococci (CONs) 7/56(12.5%), Enterococcus Spp.6/56 (10.7%), Candida albicans 10/56(17.9%) and Non-albicans Candida Spp. 9/56(16.1%) were the commonest isolated uropathogens. In this study uropathogens were significantly associated with being type II diabetes patient and having previous UTI history. Both gram positive and gram negative bacteria showed resistance to most tested antibiotics. Drug resistance to two or more drugs was observed in 81.1% of bacterial isolates.

Conclusion

High prevalence of uropathogens and increased rate of Multi-drug resistance was shown in this study. Therefore, continued surveillance on uropathogens prevalence and resistance rates is needed to ensure appropriate recommendations for the empirical treatment, develop rational prescription programs and make policy decisions.
Literature
1.
go back to reference Al-Qaseer A, Abdul-wahab BH, Abbas OK. Bacteriological finding of urinary tract infection in diabetic patients. Int. J. Adv. Res. 2014;2(10):274–9. Al-Qaseer A, Abdul-wahab BH, Abbas OK. Bacteriological finding of urinary tract infection in diabetic patients. Int. J. Adv. Res. 2014;2(10):274–9.
2.
go back to reference Pramod KJ, Ratna B, Basudha K. Prevalence of Uropathogens in diabetic patients and their susceptibility pattern at a tertiary Care Center in Nepal-a Retrospective Study. IJBLS. 2014;3(2):29–34. Pramod KJ, Ratna B, Basudha K. Prevalence of Uropathogens in diabetic patients and their susceptibility pattern at a tertiary Care Center in Nepal-a Retrospective Study. IJBLS. 2014;3(2):29–34.
3.
go back to reference Sahib AKY. Study of ciprofloxacin resistant Escherichia Coli (CREC) in type 2 diabetic patients with symptomatic urinary tract infection. Iraq J comm Med. 2008;21(1):58–63. Sahib AKY. Study of ciprofloxacin resistant Escherichia Coli (CREC) in type 2 diabetic patients with symptomatic urinary tract infection. Iraq J comm Med. 2008;21(1):58–63.
4.
go back to reference Baqai R, Aziz M, Rasool G. Urinary tract infection in diabetic patients and biofilm formation of uropathogens. Infect. Dis. J Pak. 2008;17(1):7–9. Baqai R, Aziz M, Rasool G. Urinary tract infection in diabetic patients and biofilm formation of uropathogens. Infect. Dis. J Pak. 2008;17(1):7–9.
5.
go back to reference Njunda AL, Assob NJC, Nsagha SD, Nde FP, Kamga FHL, Nkume AF, et al. Uropathogens from diabetic patients with asymptomatic bacteriuria and urinary tract infections. West Lond. Med. J. 2013;5(1):7–14. Njunda AL, Assob NJC, Nsagha SD, Nde FP, Kamga FHL, Nkume AF, et al. Uropathogens from diabetic patients with asymptomatic bacteriuria and urinary tract infections. West Lond. Med. J. 2013;5(1):7–14.
6.
go back to reference Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16(1):s27–36.PubMedPubMedCentral Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16(1):s27–36.PubMedPubMedCentral
7.
go back to reference Pargavi B, Mekala T, Thamarai Selvi A, Moorthy K. Prevalence of urinary tract infection (UTI) among diabetics patients in Vandavasi, Tamil Nadu, India. IJBT. 2011;2(2):42–5. Pargavi B, Mekala T, Thamarai Selvi A, Moorthy K. Prevalence of urinary tract infection (UTI) among diabetics patients in Vandavasi, Tamil Nadu, India. IJBT. 2011;2(2):42–5.
8.
go back to reference Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infection: pathogenesis. Clin Infect Dis. 2011;52(6):S437–51.CrossRef Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infection: pathogenesis. Clin Infect Dis. 2011;52(6):S437–51.CrossRef
9.
go back to reference Fisher JF. Candida urinary tract infection- epidemiology, pathogenesis, diagnosis and treatment: executive summary. Clin Infect Dis. 2011;52(3):S429–32.CrossRef Fisher JF. Candida urinary tract infection- epidemiology, pathogenesis, diagnosis and treatment: executive summary. Clin Infect Dis. 2011;52(3):S429–32.CrossRef
10.
go back to reference Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women. Clin Infect Dis. 2011;52:03–20.CrossRef Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women. Clin Infect Dis. 2011;52:03–20.CrossRef
11.
go back to reference Kofteridis DP, Papadimitraki E, Mantadakis E, Maraki S, Papadakis JA, Tzifa G, et al. Effect of diabetes mellitus on the clinical and microbiological features of hospitalized elderly patients with acute pyelonephritis. J Am Geriatr Soc. 2009;57:2125–8.CrossRef Kofteridis DP, Papadimitraki E, Mantadakis E, Maraki S, Papadakis JA, Tzifa G, et al. Effect of diabetes mellitus on the clinical and microbiological features of hospitalized elderly patients with acute pyelonephritis. J Am Geriatr Soc. 2009;57:2125–8.CrossRef
12.
go back to reference Alanis AJ. Resistance to antibiotic: are we in the post-antibiotic era? Arch Med Res. 2005;36(6):697–705.CrossRef Alanis AJ. Resistance to antibiotic: are we in the post-antibiotic era? Arch Med Res. 2005;36(6):697–705.CrossRef
13.
go back to reference World Health Organization. Definition, Diagnosis and Classification of diabetes mellitus and its complications; Part 1: Diagnosis and Classification of diabetes mellitus, Geneva. Department of non-communicable Disease Surveillance. WHO, 2003. World Health Organization. Definition, Diagnosis and Classification of diabetes mellitus and its complications; Part 1: Diagnosis and Classification of diabetes mellitus, Geneva. Department of non-communicable Disease Surveillance. WHO, 2003.
14.
go back to reference Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests. Twenty-second informational supplement. CLIS. 2014;32(3):M100–S22. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests. Twenty-second informational supplement. CLIS. 2014;32(3):M100–S22.
15.
go back to reference Yeshitela B, Gebre-Selassie S, Feleke Y. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in TikurAnbessa Specialized University hospital. Addis Ababa, Ethiopia. Ethiop Med J. 2012;50(3):239–49.PubMed Yeshitela B, Gebre-Selassie S, Feleke Y. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in TikurAnbessa Specialized University hospital. Addis Ababa, Ethiopia. Ethiop Med J. 2012;50(3):239–49.PubMed
16.
go back to reference Yismaw G, Asrat D, Woldeamanuel Y, Unakal CG. Urinary tract infection: bacterial etiologies, drug resistance profile and associated risk factors in diabetic patients attending Gondar University hospital, Gondar, Ethiopia. Euro J Exp Bio. 2012;2(4):889–98. Yismaw G, Asrat D, Woldeamanuel Y, Unakal CG. Urinary tract infection: bacterial etiologies, drug resistance profile and associated risk factors in diabetic patients attending Gondar University hospital, Gondar, Ethiopia. Euro J Exp Bio. 2012;2(4):889–98.
17.
go back to reference Hamdan ZH, Eman K, Amar MA, Onab SH, Sarah OS, Ishag A. Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan. Ann Clin Microbiol Antimicrob. 2015;14(26):1–6. Hamdan ZH, Eman K, Amar MA, Onab SH, Sarah OS, Ishag A. Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan. Ann Clin Microbiol Antimicrob. 2015;14(26):1–6.
18.
go back to reference Osanyinpeju OS, Akinleye OM, Deji AM, Olaniyan JT, Akintunde BG, Buhari OA. Asymptomatic urinary tract infection in diabetic patients in ago –Iwoye, Ogun state. Nigeria J Am Sci. 2014;10(4s):72–8. Osanyinpeju OS, Akinleye OM, Deji AM, Olaniyan JT, Akintunde BG, Buhari OA. Asymptomatic urinary tract infection in diabetic patients in ago –Iwoye, Ogun state. Nigeria J Am Sci. 2014;10(4s):72–8.
19.
go back to reference Chaudhary BL, Charu C, Shukla S. Bacteriology of urinary tract infection and antibiotic susceptibility pattern among diabetic patients. Int J Bioassays. 2014;3(08):3224–7. Chaudhary BL, Charu C, Shukla S. Bacteriology of urinary tract infection and antibiotic susceptibility pattern among diabetic patients. Int J Bioassays. 2014;3(08):3224–7.
20.
go back to reference Muhammad I, Saeed A, Sohaib MK, Moeez H, Imtiaz HB. Urinary tract infection in diabetic patients; causative bacteria and antibiotic sensitivity. J Med Sci. 2014;22(3):110–4. Muhammad I, Saeed A, Sohaib MK, Moeez H, Imtiaz HB. Urinary tract infection in diabetic patients; causative bacteria and antibiotic sensitivity. J Med Sci. 2014;22(3):110–4.
21.
go back to reference Yismaw G, Asrat D, Woldeamanuel Y, Unakal C. Prevalence of Candiduria in diabetic patients attending Gondar University hospital, Gondar, Ethiopia. Iran. J. Kidney Dis. 2013;7(2):102–7.PubMed Yismaw G, Asrat D, Woldeamanuel Y, Unakal C. Prevalence of Candiduria in diabetic patients attending Gondar University hospital, Gondar, Ethiopia. Iran. J. Kidney Dis. 2013;7(2):102–7.PubMed
22.
go back to reference Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906–12.CrossRef Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906–12.CrossRef
23.
go back to reference Awwad KCandiduria in diabetic patients in Arar northern area, Saudi Arabia. Life Sci J. 2014;11(1):336–70. Awwad KCandiduria in diabetic patients in Arar northern area, Saudi Arabia. Life Sci J. 2014;11(1):336–70.
24.
go back to reference Zia SN, Hassanshahi G. The frequency of coagulase negative staphylococci urinary infections with antimicrobial resistance pattern in Rafsanjan. Pak J Med Sci. 2010;26(1):107–10. Zia SN, Hassanshahi G. The frequency of coagulase negative staphylococci urinary infections with antimicrobial resistance pattern in Rafsanjan. Pak J Med Sci. 2010;26(1):107–10.
25.
go back to reference Geerlings SE, Stolk RP, Camps MJ, Netten PM, Hoekstra JB, Bouter KP, et al. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes mellitus women asymptomatic bacteriuria Utrecht-study group. Diabetes Care. 2000;23:744–9.CrossRef Geerlings SE, Stolk RP, Camps MJ, Netten PM, Hoekstra JB, Bouter KP, et al. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes mellitus women asymptomatic bacteriuria Utrecht-study group. Diabetes Care. 2000;23:744–9.CrossRef
26.
go back to reference Ghenghesh KS, Elkateb E, Berbash N, Abdel Nada R, Ahmed SF, Rahouma A, et al. Uropathogens from diabetic patients in Libya: virulence factors and phylogenetic groups of Escherichia coli isolates. J Med Microbiol. 2009;58(8):1006–14.CrossRef Ghenghesh KS, Elkateb E, Berbash N, Abdel Nada R, Ahmed SF, Rahouma A, et al. Uropathogens from diabetic patients in Libya: virulence factors and phylogenetic groups of Escherichia coli isolates. J Med Microbiol. 2009;58(8):1006–14.CrossRef
27.
go back to reference Rijal M, Neupane B, Bhandari P, Aryal S. Asymptomatic bacteriuria in elderly patients with diabetes attending a tertiary care center. J Trop Dis. 2015;3(3):1–3. Rijal M, Neupane B, Bhandari P, Aryal S. Asymptomatic bacteriuria in elderly patients with diabetes attending a tertiary care center. J Trop Dis. 2015;3(3):1–3.
28.
go back to reference Beyene G, Tsegaye W. Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in Jimma University specialized hospital, Southwest Ethiopia. Ethiop J Health Sci. 2011;21(2):141–6.CrossRef Beyene G, Tsegaye W. Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in Jimma University specialized hospital, Southwest Ethiopia. Ethiop J Health Sci. 2011;21(2):141–6.CrossRef
29.
go back to reference Riaz S, Rana S. Analysis of Uropathogenes among type II diabetic patients in Pakistani population. Advances in Diabetes and Metabolism. 2014;2(2):31–41. Riaz S, Rana S. Analysis of Uropathogenes among type II diabetic patients in Pakistani population. Advances in Diabetes and Metabolism. 2014;2(2):31–41.
30.
go back to reference Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and streptococcus pyogenes. Emerg Infect Dis. 2004;10(3):514–7.CrossRef Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and streptococcus pyogenes. Emerg Infect Dis. 2004;10(3):514–7.CrossRef
Metadata
Title
Common uropathogens and their antibiotic susceptibility pattern among diabetic patients
Authors
Hiwot Ketema Woldemariam
Dereje Assefa Geleta
Kassu Desta Tulu
Negga Asamene Aber
Melese Hailu Legese
Genet Molla Fenta
Ibrahim Ali
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3669-5

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.